{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:43:06Z","timestamp":1773387786270,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.arcped.2005.10.021","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T13:30:20Z","timestamp":1135258220000},"page":"140-145","source":"Crossref","is-referenced-by-count":19,"title":["Enc\u00e9phalopathie induite par\u00a0l'ifosfamide\u00a0: 15\u00a0observations"],"prefix":"10.1016","volume":"13","author":[{"given":"C.","family":"Dufour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Grill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sabouraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Behar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Munzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Motte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Oberlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Paci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2005.10.021_bib1","first-page":"921","article-title":"Unexpected toxicity in patients treated with ifosfamide","volume":"32","author":"Van Dyck","year":"1972","journal-title":"Cancer Res."},{"key":"10.1016\/j.arcped.2005.10.021_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1200\/JCO.1990.8.1.170","article-title":"High dose ifosfamide with mesna uroprotection: a phase I study","volume":"8","author":"Elias","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0305-7372(85)90011-8","article-title":"Ifosfamide pharmacology, safety and therapeutic potential","volume":"12","author":"Brade","year":"1985","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.arcped.2005.10.021_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0929-693X(03)00105-2","article-title":"Toxicit\u00e9 centrale des chimioth\u00e9rapies\u00a0: \u00e9tat des connaissances actuelles","volume":"10","author":"Orbach","year":"2003","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.arcped.2005.10.021_bib5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1200\/JCO.1986.4.8.1253","article-title":"Central nervous system toxicity following the treatment of pediatric patients with ifosfamide\/mesna","volume":"4","author":"Pratt","year":"1986","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00163537","article-title":"Severe encephalopathy associated with ifosfamide administration in two children with metastatic tumors","volume":"6","author":"Gieron","year":"1988","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/08880018909034311","article-title":"Fatal encephalopathy with ifosfamide\/mesna","volume":"6","author":"Verdeguer","year":"1989","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1200\/JCO.1987.5.3.512","article-title":"Ifosfamide neurotoxicity","volume":"5","author":"Kellie","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0090-8258(91)90344-5","article-title":"Ifosfamide induced neurotoxicity","volume":"42","author":"Curtin","year":"1991","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0140-6736(90)90053-8","article-title":"Ifosfamide by continuous infusion to prevent encephalopathy","volume":"335","author":"Cerny","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.021_bib11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0140-6736(87)91769-7","article-title":"Encephalopathy with rapid infusion ifosfamide\/mesna","volume":"1","author":"Perren","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.021_bib12","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0277-5379(89)90077-1","article-title":"Ifosfamide encephalopathy: a reappraisal","volume":"25","author":"Watkin","year":"1989","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0277-5379(86)90368-8","article-title":"Prediction of ifosfamide\u2013mesna associated encephalopathy","volume":"22","author":"Meanwell","year":"1986","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(85)91432-1","article-title":"Encephalopathy associated with ifosphamide\u2013mesna therapy","volume":"1","author":"Meanwell","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.021_bib15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/oxfordjournals.annonc.a058317","article-title":"The enigma of ifosfamide encephalopathy","volume":"3","author":"Cerny","year":"1992","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1600-0404.1992.tb05136.x","article-title":"Encephalopathy in ifosfamide-treated patients","volume":"86","author":"Merimsky","year":"1992","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.arcped.2005.10.021_bib17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00001813-200404000-00006","article-title":"Incidence and severity of ifosfamide-induced encephalopathy","volume":"15","author":"Rieger","year":"2004","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.arcped.2005.10.021_bib18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(85)91288-7","article-title":"Ifosfamide\u2013mesa and encephalopathy","volume":"1","author":"Cantwell","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.021_bib19","first-page":"103","article-title":"Enc\u00e9phalopathies \u00e0 l'Holoxan","volume":"2","author":"Antoine","year":"1993","journal-title":"Cah. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0936-6555(03)00114-6","article-title":"Methylene blue for the treatment and prophylaxis of ifosfamide-induced encephalopathy","volume":"15","author":"Turner","year":"2003","journal-title":"Clin. Oncol. (R Coll Radiol)"},{"key":"10.1016\/j.arcped.2005.10.021_bib21","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/0277-5379(91)90330-G","article-title":"Ifosfamide-related acute encephalopathy: clinical and radiological aspects","volume":"27","author":"Merimsky","year":"1991","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.arcped.2005.10.021_bib22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archneur.1993.00540100089024","article-title":"Ifosfamide-induced nonconvulsive status epilepticus","volume":"50","author":"Wengs","year":"1993","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arcped.2005.10.021_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2165\/00003495-199142030-00006","article-title":"Ifosfamide\u2013mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer","volume":"42","author":"Dechant","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.arcped.2005.10.021_bib24","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(86)92227-0","article-title":"Dechloroethylation of ifosfamide and neurotoxicity","volume":"2","author":"Goren","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.021_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00003088-200140010-00004","article-title":"Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites","volume":"40","author":"Kerbusch","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.arcped.2005.10.021_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1054\/bjoc.1999.0917","article-title":"Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature","volume":"82","author":"Pelgrims","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.arcped.2005.10.021_bib27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-3565(24)38206-0","article-title":"Inhibition and stimulation of long-chain fatty acid oxidation by chloroacetaldehyde and methylene blue in rats","volume":"289","author":"Visarius","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arcped.2005.10.021_bib28","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1056\/NEJM199505043321817","article-title":"Methylene blue for ifosfamide-associated encephalopathy","volume":"332","author":"Zulian","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arcped.2005.10.021_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s002280050102","article-title":"Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy","volume":"50","author":"Kupfer","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.arcped.2005.10.021_bib30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0140-6736(94)91839-2","article-title":"Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue","volume":"343","author":"Kupfer","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.021_bib31","first-page":"598","article-title":"Traitement de l'enc\u00e9phalopathie \u00e0 l'Ifosfamide par le bleu de m\u00e9thyl\u00e8ne","volume":"82","author":"Ferrero","year":"1995","journal-title":"Bull. Cancer"},{"key":"10.1016\/j.arcped.2005.10.021_bib32","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/oxfordjournals.annonc.a010686","article-title":"Ifosfamide encephalopathy and methylene-blue: a case report","volume":"7","author":"Alonso","year":"1996","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib33","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0140-6736(65)90111-X","article-title":"Methylene blue in alcohol-induced hypoglycaemia","volume":"2","author":"Greenberg","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.021_bib34","first-page":"1336","article-title":"Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue","volume":"24","author":"Aeschlimann","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.arcped.2005.10.021_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00405909","article-title":"Central nervous system effect following ifosfamide monotherapy of advanced renal carcinoma","volume":"100","author":"Heim","year":"1981","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib36","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1200\/JCO.1990.8.8.1399","article-title":"Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors","volume":"8","author":"Pratt","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(86)90099-1","article-title":"Avoiding ifosfamide\u2013mesna encephalopathy","volume":"2","author":"Meanwell","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.021_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.1989.7.1.126","article-title":"Response to ifosfamide and mesna\u00a0: 124 previously treated patients with metatastic or unresectable sarcoma","volume":"7","author":"Antman","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib39","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(87)90343-6","article-title":"Ifosfamide\u2013mesna encephalopathy","volume":"1","author":"McCallum","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.021_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/00043426-200402000-00010","article-title":"Methylene blue reversal of ifosfamide-related encephalopathy","volume":"26","author":"Raj","year":"2004","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.arcped.2005.10.021_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00520-003-0573-2","article-title":"Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?","volume":"12","author":"Kasper","year":"2004","journal-title":"Support. Care Cancer"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X05005944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X05005944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T18:37:02Z","timestamp":1736188622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X05005944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0929693X05005944"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2005.10.021","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}